Physician profile
Thomas P Hawk
NPI 1104823442
$625.23
in general payments reported to CMS, 2019-2025
13 companies · $24.86 in 2025
The $24.86 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $512 · 2020: $19.28 · 2024: $69.30 · 2025: $24.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $94.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $94.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $191.79 | 2019 | |
| Biotissue Holdings INC. | $94.16 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $67.63 | 2019 | |
| Novartis Pharmaceuticals Corporation | $45.66 | 2019 | |
| Shire North American Group INC | $44.66 | 2019 | |
| Mallinckrodt Enterprises LLC | $41.14 | 2019 | |
| Notal Vision, INC. | $22.77 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $22.18 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $20.43 | 2019 | |
| Aerie Pharmaceuticals, INC. | $20.23 | 2019 | |
| Allergan, INC. | $19.28 | 2020 | |
| Kala Pharmaceuticals, INC. | $17.91 | 2019 | |
| Ocular Therapeutix, INC. | $17.39 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Hawk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.